Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Recommendations for statin therapy in the elderly].

S Döser1, W März, M-F Reinecke

  • 1IV. Medizinische Klinik, Fakultät für Klinische Medizin Mannheim, Ruprecht-Karls-Universität Heidelberg.

Der Internist
|September 2, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Evaluation of QTc Interval Prolongation With the Dual Endothelin Receptor Antagonist Aprocitentan.

Journal of cardiovascular pharmacology and therapeutics·2025
Same author

Microplastics and chemical additives from disposable face masks: Environmental, human health and behavioural impacts.

The Science of the total environment·2025
Same author

Sex differences in survival from melanoma of the skin: The role of age, anatomic location and stage at diagnosis: A CONCORD-3 study in 59 countries.

European journal of cancer (Oxford, England : 1990)·2025
Same author

The progression of basaltic-rhyolitic melt storage at Yellowstone Caldera.

Nature·2025
Same author

Innovative transgenic zebrafish biosensor for heavy metal detection.

Environmental pollution (Barking, Essex : 1987)·2024
Same author

A Small Device May Deliver King-Sized Solutions for Patients With an Exacerbation of Cystic Fibrosis.

International journal of pediatrics·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
See all related articles

Elderly patients benefit from statin therapy, reducing mortality and morbidity. Guidelines recommend statins for those up to 79, and select high-risk individuals aged 80 and above.

Area of Science:

  • Cardiology
  • Geriatrics
  • Pharmacology

Background:

  • Elderly patients are less likely to receive statins due to concerns about compliance, adverse events, and drug interactions.
  • Coronary heart disease (CHD) events have high clinical significance in the elderly, with 80% of coronary deaths occurring in those over 65.
  • The life expectancy of elderly patients is often underestimated, impacting treatment decisions.

Framework:

  • The HPS (Heart Protection Study) and PROSPER (Prospective Study of Pravastatin in the Elderly at Risk of Vascular Disease) trials provide evidence for statin efficacy in the elderly.
  • These studies demonstrate that statins reduce mortality and morbidity in very elderly individuals with high cardiovascular risk or coronary artery disease (CAD).

Implementation:

  • Patients up to age 79 should be treated with statins according to established cardiovascular guidelines.

Related Experiment Videos

  • Statin therapy for patients aged 80 and older should be considered on an individual basis for those at very high risk of cardiovascular events.

    • Implications:

    • Optimizing statin therapy in the elderly can significantly reduce cardiovascular mortality and morbidity.
    • Evidence supports the use of statins in older populations, challenging previous underestimations of their benefit and life expectancy.
    • Clinical guidelines should reflect the proven benefits of statins across a wider elderly demographic, with careful consideration for the oldest individuals.